Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
To identify the novel miRNA markers for arteriosclerosis, we screened total RNA samples derived from patient's plasma using a microarray platform. We found that several circulating miRNAs were differentially expressed. We also demonstrated that expression of miRNAs was altered by various cytokine that induced the inflammation state in the human umbilical cord vein endothelial cells (HUVECs). Furthermore, we investigated the optimal RNA extraction method of miRNA from plasma samples for quantitative PCR. These results suggest that circulating miRNAs are available as a novel biomarker to assess the arteriosclerosis.
|